1 option
CADTH Canadian Drug Expert Committee final recommendation : indication : to reduce blood phenylalanine levels in patients with hyperphenylalaninemia due to BH4-responsive phenylketonuria. Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) / CADTH Canadian Drug Expert Committee.
- Format:
- Book
- Author/Creator:
- CADTH Canadian Drug Expert Committee, author, issuing body.
- Language:
- English
- Subjects (All):
- Drugs--Safety measures.
- Drugs.
- Drugs--Handbooks, manuals, etc.
- Physical Description:
- 1 online resource
- Place of Publication:
- Ottawa, ON : Canadian Agency for Drugs and Technologies in Health, 2016.
- Summary:
- The CADTH Canadian Drug Expert Committee (CDEC) recommends that sapropterin, in conjunction with a phenylalanine (Phe)-restricted diet, be reimbursed to reduce blood Phe levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin (BH4)-responsive phenylketonuria (PKU).
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.